Dec 13th, 2023
Nestle CEO Doesn’t See Weight-Loss Drugs as Threat to Business
Nestle CEO Mark Schneider says the world’s largest food company doesn’t see GLP-1 weight-loss drugs as a threat, but rather “a full-blown vindication of the strategy that we’ve been pursuing very patiently over the years.” He speaks with Francine Lacqua.
